A new Artificial Intelligence (AI) model recorded a reduction in the failure rate of colorectal neoplasia by almost 50% according to the study.
Study published in the magazine Gastroenterology showed the effectiveness of AI to improve this type of medical intervention. The study involved 230 patients, who underwent colorectal cancer screening or surveillance in Italy, the United Kingdom and the United States. The patients underwent two tests on the same day, which could be consecutive colonoscopies with or without AI.
Research led by Mayo Clinic specialist Michael B. Wallace showed that the adenoma failure rate using the AI model was 15.5%, and 32.4% for colonoscopy without AI. In the second interventions with AI the false negative rates were 6.8% and in the interventions without AI it was 29.6%.
"AI resulted in an approximately two-fold reduction in colorectal neoplasia failure rate, supporting the benefit of AI in reducing misperception of small, subtle lesions in standard colonoscopy," the study describes.
In the following link you can consult the abstract or summary of this study: https://linkinghub.elsevier.com/retrieve/pii/S0016-5085(22)00238-4
